small molecule therapeutics (Saniona/Boehringer Ingelheim)

N/A

Report date: 2025/03/20 15:44:30
NME

Base Information

Drug Namesmall molecule therapeutics (Saniona/Boehringer Ingelheim)
Drug Alias NameGABA alpha5 inhibitor (Saniona)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-5 inhibitors
TargetsGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsSchizophreniaDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesSaniona A/S
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsDepressive Disorder, Major
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A